RSV in the NewsThe cold months are upon us! As the temperature drops, so do our chances of staying healthy. Unfortunately, this means that respiratory infections like RSV (respiratory syncytial virus) are on... By Editorial Team2 min readBookmark for later Reactions 0 reactions Comments0 comments
Cigarette Maker Transitioning to Inhalers?Phillip Morris has been in the news recently. The word is that they have purchased Vectura, a company that makes inhalers and nebulizers. So this begins the transition of a... By John Bottrell, RRT3 min readBookmark for later Reactions 0 reactions Comments0 comments
Philips Ventilator Recall: What You Need to KnowPhilips Respironics has recalled more than 16,000 ventilators in the United States due to a problem with the machines' oxygen flow. The recall affects 2 ventilator models sold between May... By Editorial Team2 min readBookmark for later Reactions 0 reactions Comments0 comments
What to Know About Philips CPAP and Ventilator RecallAfter many months of investigation, Philips has announced a recall notification for many of its devices. The medical device company analyzed risks related to several products, including:1,2 In the United... By Editorial Team2 min readBookmark for later Reactions 0 reactions Comments1 comments
Breztri Aerosphere™ Approved to Treat COPDBreztri Aerosphere is a single-inhaler, fixed-dose combination of 3 drugs that has been approved by the FDA for the maintenance treatment of COPD. It was formerly known as PT010.1 The... By Editorial Team2 min readBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves First Generic of Proventil HFA, A Commonly Used Albuterol InhalerThe United States Food and Drug Administration (US FDA) has approved the first generic of Proventil HFA metered-dose inhaler. This is an especially important approval for the COVID-19 pandemic response... By Editorial Team2 min readBookmark for later Reactions 0 reactions Comments0 comments
Take the Fatigue and Health Survey!The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given... By Editorial Team3 min readBookmark for later Reactions 0 reactions Comments4 comments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can... By Editorial Team5 min readBookmark for later Reactions 0 reactions Comments5 comments
Congratulations to New York State!The State of New York just raised the minimum age required to purchase tobacco and electronic cigarette products age from 18 to 21. The law went into effect November 13... By KevinDavitt3 min readBookmark for later Reactions 0 reactions Comments3 comments
Take the Chronic Pain In America Survey! (Now Closed)We know the frustrations of chronic pain. Will you help others understand by taking our survey? Simply put, living with chronic pain is painful. But there is so much more... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
Take The Clinical Trial Patient Voice Survey (Now Closed)Have you participated in a clinical trial? Are you interested in participating in future clinical trials? We want to hear more about your experience! COPD.net/Health Union is teaming up with... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
Introducing our New Accessibility FeatureYou may have noticed that we added a new accessibility feature to our websites. This feature will allow community members to change the size, color, or contrast of the text... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments5 comments
First Advair Diskus Generic Approval Announced by FDAOn Wednesday January 30th, 2019, the United States Food and Drug Administration (FDA) announced that they have approved a generic alternative to the medication Advair Diskus (fluticasone propionate and salmeterol... By Editorial Team2 min readBookmark for later Reactions 0 reactions Comments3 comments
Take the COPD in the Bedroom Survey!We know that COPD can bring a variety of symptoms as well as have an impact on one’s daily life. However, we’ve also heard from COPD patients that it can... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments12 comments
How's Your Relationship with Your Doctor? Take our Survey!Do you feel heard by your doctor? Do your questions get answered? We want to hear from you! We’re conducting a survey to learn more about your relationship with your... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
Take the Clinical Trial Patient Experience Survey!Have you participated in a clinical trial? We want to hear more about your experience! We are conducting a short survey to understand how patients are involved in the clinical... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
New Look, Same Great Community!You might notice a few changes in the way things look when you visit our COPD.net. Never fear! You still have the same tools for finding info and connecting with... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
Take the Online Health Resource Survey!Managing a chronic health condition like COPD can be overwhelming at times. How do you find reliable information? Where do you go to find a supportive community? What features matter... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
What You Asked the Experts!In preparation for COPD Awareness Month, we asked YOU what you'd ask the experts! Here are the questions - and responses! - the community wanted to learn about. Response from... By Editorial Team5 min readBookmark for later Reactions 0 reactions Comments7 comments
